BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 34024444)

  • 1. A Review of Clostridioides difficile Infection and Antibiotic-Associated Diarrhea.
    Abad CLR; Safdar N
    Gastroenterol Clin North Am; 2021 Jun; 50(2):323-340. PubMed ID: 34024444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
    Khanna S; Assi M; Lee C; Yoho D; Louie T; Knapple W; Aguilar H; Garcia-Diaz J; Wang GP; Berry SM; Marion J; Su X; Braun T; Bancke L; Feuerstadt P
    Drugs; 2022 Oct; 82(15):1527-1538. PubMed ID: 36287379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An insight into
    Thabit AK; Aljedaani HJ; Alghamdi RH; Badahdah RM; Lashkar MO; Alnajjar A
    Expert Rev Gastroenterol Hepatol; 2023; 17(8):805-810. PubMed ID: 37480286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the diagnosis and treatment of Clostridium difficile infections.
    Peng Z; Ling L; Stratton CW; Li C; Polage CR; Wu B; Tang YW
    Emerg Microbes Infect; 2018 Feb; 7(1):15. PubMed ID: 29434201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antibiotic to induce Clostridioides difficile-susceptibility and infectious strain in a mouse model of Clostridioides difficile infection and recurrence.
    Castro-Córdova P; Díaz-Yáñez F; Muñoz-Miralles J; Gil F; Paredes-Sabja D
    Anaerobe; 2020 Apr; 62():102149. PubMed ID: 31940467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter study of the epidemiology of Clostridioides difficile infection and recurrence in southern Brazil.
    Maestri AC; Raboni SM; Morales HMP; Ferrari LF; Tuon FFB; Losso A; Marconi C; Nogueira KDS
    Anaerobe; 2020 Aug; 64():102238. PubMed ID: 32717474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic exposure and the risk of hospital-acquired diarrhoea and Clostridioides difficile infection: a cohort study.
    Schechner V; Fallach N; Braun T; Temkin E; Carmeli Y
    J Antimicrob Chemother; 2021 Jul; 76(8):2182-2185. PubMed ID: 33969419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridioides difficile Infection in Children: Recent Updates on Epidemiology, Diagnosis, Therapy.
    Shirley DA; Tornel W; Warren CA; Moonah S
    Pediatrics; 2023 Sep; 152(3):. PubMed ID: 37560802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frontiers in antibiotic alternatives for
    Phanchana M; Harnvoravongchai P; Wongkuna S; Phetruen T; Phothichaisri W; Panturat S; Pipatthana M; Charoensutthivarakul S; Chankhamhaengdecha S; Janvilisri T
    World J Gastroenterol; 2021 Nov; 27(42):7210-7232. PubMed ID: 34876784
    [No Abstract]   [Full Text] [Related]  

  • 10. [Side effects of antibiotic: diarrhea and Clostridium difficile infection.].
    Capurso L; Koch M
    Recenti Prog Med; 2021 Jan; 112(1):4-26. PubMed ID: 33576348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clostridioides difficile: updated recommendations].
    Barbut F; Eckert C; Lalande V; Le Neindre K; Couturier J
    Rev Prat; 2022 Sep; 72(7):703-709. PubMed ID: 36511953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridioides difficile infection evaluation and management in the emergency department.
    Carius BM; Liang SY; Koyfman A; Long B
    Am J Emerg Med; 2020 Oct; 38(10):2203-2208. PubMed ID: 33071079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial Activity of Tannic Acid
    Wang W; Cao J; Yang J; Niu X; Liu X; Zhai Y; Qiang C; Niu Y; Li Z; Dong N; Wen B; Ouyang Z; Zhang Y; Li J; Zhao M; Zhao J
    Microbiol Spectr; 2023 Feb; 11(1):e0261822. PubMed ID: 36537806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Look What the Cat Dragged in! Recurrent Clostridioides difficile from a Household Cat.
    Garza MA; Thomas B; Saleh A; Nabbout L; Quigley EMM; Mathur N
    Am J Case Rep; 2023 Oct; 24():e940923. PubMed ID: 37885171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clostridioides difficile infections].
    van Prehn J; Chernova VO; Vendrik KEW; Kuijper EJ
    Ned Tijdschr Geneeskd; 2023 Oct; 167():. PubMed ID: 37850615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new score to predict Clostridioides difficile infection in medical patients: a sub-analysis of the FADOI-PRACTICE study.
    Mumoli N; Bonaventura A; Marchesi C; Cei M; Morbidoni L; Donatiello I; Mazzone A; Dentali F
    Intern Emerg Med; 2023 Oct; 18(7):2003-2009. PubMed ID: 37633862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridioides difficile: Current overview and future perspectives.
    Giles J; Roberts A
    Adv Protein Chem Struct Biol; 2022; 129():215-245. PubMed ID: 35305720
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Giuliani A; Lerco S; Manani SM; Marcello M; Tantillo I; Nicolin R; Ronco C; Zanella M
    Perit Dial Int; 2023 Mar; 43(2):182-185. PubMed ID: 36350040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and treatment of Clostridioides difficile infection.
    Mateu L; Fernández-Rivas G; Sopena N
    Med Clin (Barc); 2020 Jul; 155(1):30-35. PubMed ID: 32430207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection.
    Dieterle MG; Putler R; Perry DA; Menon A; Abernathy-Close L; Perlman NS; Penkevich A; Standke A; Keidan M; Vendrov KC; Bergin IL; Young VB; Rao K
    mBio; 2020 May; 11(3):. PubMed ID: 32371595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.